Cite
HARVARD Citation
Gainor, J. et al. (2016). Dramatic Response to Combination Erlotinib and Crizotinib in a Patient with Advanced, EGFR‐Mutant Lung Cancer Harboring De NovoMETAmplification. Journal of thoracic oncology. 11 (7), p. . [Online].